PANIC
MCID: PNC025
MIFTS: 60

Panic Disorder (PANIC) malady

Categories: Genetic diseases (common), Mental diseases

Aliases & Classifications for Panic Disorder

About this section

Aliases & Descriptions for Panic Disorder:

Name: Panic Disorder 52 11 50 38 39 13 68
Panic Disorder 1 27 68
Panic Disorder Syndrome 1 12
 
Panic Anxiety Syndrome 11
Panic 50

Classifications:



External Ids:

OMIM52 167870
Disease Ontology11 DOID:594
MeSH39 D016584
NCIt45 C34890
ICD1030 F41.0

Summaries for Panic Disorder

About this section
OMIM:52 The DSM-IV (American Psychiatric Association, 1994) defines panic disorder as the spontaneous, unexpected occurrence of... (167870) more...

MalaCards based summary: Panic Disorder, also known as panic disorder 1, is related to personality disorder and schizophrenia, and has symptoms including anxiety An important gene associated with Panic Disorder is COMT (Catechol-O-Methyltransferase), and among its related pathways are Cell-type Dependent Selectivity of CCK2R Signaling and Dopamine metabolism. The drugs imipramine and fluoxetine have been mentioned in the context of this disorder. Affiliated tissues include heart, cortex and brain, and related mouse phenotypes are Decreased viability and Increased transferrin (TF) endocytosis.

MedlinePlus:38 Panic disorder is a type of anxiety disorder. it causes panic attacks, which are sudden feelings of terror when there is no real danger. you may feel as if you are losing control. you may also have physical symptoms, such as fast heartbeat chest or stomach pain breathing difficulty weakness or dizziness sweating feeling hot or a cold chill tingly or numb hands panic attacks can happen anytime, anywhere, and without warning. you may live in fear of another attack and may avoid places where you have had an attack. for some people, fear takes over their lives and they cannot leave their homes. panic disorder is more common in women than men. it usually starts when people are young adults. sometimes it starts when a person is under a lot of stress. most people get better with treatment. therapy can show you how to recognize and change your thinking patterns before they lead to panic. medicines can also help. nih: national institute of mental health

Disease Ontology:11 An anxiety disorder that is characterized by unexpected and repeated episodes of intense fear accompanied by physical symptoms that may include chest pain, heart palpitations, shortness of breath, dizziness, or abdominal distress.

Wikipedia:71 Panic disorder is an anxiety disorder characterized by recurrent unexpected panic attacks. Panic attacks... more...

Related Diseases for Panic Disorder

About this section

Diseases in the Panic Disorder family:

Panic Disorder 3 Panic Disorder 2

Diseases related to Panic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 138)
idRelated DiseaseScoreTop Affiliating Genes
1personality disorder29.3CCK, COMT, CRH, HTR1A, HTR2A, MAOA
2schizophrenia28.2ADORA2A, CCK, CCKAR, COMT, HTR1A, HTR2A
3panic disorder 312.1
4panic disorder 212.0
5anxiety disorder11.4
6agoraphobia10.9
7generalized anxiety disorder10.4
8social phobia10.3
9obsessive-compulsive disorder10.3
10polyneuropathy10.2HTR1A, HTR2A
11cholestasis-lymphedema syndrome10.2COMT, MAOA
12antisocial personality disorder10.2HTR1A, HTR2A
13strongyloidiasis10.2COMT, MAOA, SLC6A4
14neurogenic bladder10.2HTR2A, MAOA, SLC6A4
15aryepiglottic fold cancer10.2HTR1A, HTR2A
16pyromania10.2HTR2A, MAOA, SLC6A4
17nephronophthisis 1310.2COMT, HTR2A, SLC6A4
18tinea pedis10.2HTR1A, MAOA, SLC6A4
19apperceptive agnosia10.2COMT, HTR1A, SLC6A4
20conjunctival pigmentation10.2CRH, MAOA, SLC6A4
21dry eye syndrome10.2HTR1A, HTR2A, SLC6A4
22waardenburg's syndrome10.2HTR1A, HTR2A, SLC6A4
23acute contagious conjunctivitis10.2CCK, CCKAR, CCKBR
24gastrointestinal neuroendocrine benign tumor10.1CCK, TSPO
25primary angle-closure glaucoma10.1COMT, HTR1A, HTR2A, SLC6A4
26alexithymia10.1
27hypereosinophilic syndrome10.1MAOA, POMC, SLC6A4
28abnormal pupillary function10.1HTR1A, HTR3A
29separation anxiety disorder10.1
30hypochondriasis10.1
31anodontia10.1HTR1A, HTR3A, SLC6A4
32adult brainstem astrocytoma10.1CCKBR, HTR1A, MAOA, PTK7, SLC6A4
33sweat gland cancer10.0CCK, HTR3A, SLC6A4
34intermittent squint10.0CRH, POMC
35cholesteatoma10.0CCK, COMT, POMC, SLC6A4
36hypoglycemia10.0CRH, POMC, SLC6A4
37autoimmune disease of endocrine system10.0CRH, POMC, TSPO
38siberian tick typhus10.0HTR1A, HTR3A, TSPO
39chronic eosinophilic pneumonia10.0COMT, CRH, HTR1A, MAOA, SLC6A4
40bipolar disorder10.0
41bartter disease10.0HTR2A, SLC6A4, TPH2
42paraphilia disorder10.0COMT, HTR2A, MAOA, SLC6A4, TPH2
43childhood malignant hemangiopericytoma10.0CCK, CCKAR, CRH
44nephrogenic adenoma of the urethra10.0HTR3A, SLC6A2, SLC6A4
45colorectal adenocarcinoma9.9COMT, MAOA, SLC6A2, SLC6A4, TPH2
46irritable bowel syndrome9.9
47ornithosis9.9CCK, HTR3A, MAOA, PTK7, SLC6A4
48asthma9.9
49somatoform disorder9.9
50thyroiditis9.9

Graphical network of the top 20 diseases related to Panic Disorder:



Diseases related to panic disorder

Symptoms & Phenotypes for Panic Disorder

About this section

Symptoms by clinical synopsis from OMIM:

167870

Clinical features from OMIM:

167870

Human phenotypes related to Panic Disorder:

 64
id Description HPO Frequency HPO Source Accession
1 anxiety64 HP:0000739

GenomeRNAi Phenotypes related to Panic Disorder according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00381-A-110.3HTR1A, HTR3A, SLC6A4
2GR00363-A7.2ADORA2A, CCKAR, CCKBR, CRH, HTR1A, HTR2A

MGI Mouse Phenotypes related to Panic Disorder according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.8CCKAR, CCKBR, COMT, CRH, HTR3A, POMC
2MP:00053798.1CCK, CCKAR, CCKBR, COMT, CRH, HTR2A
3MP:00053887.6ADORA2A, CCKAR, COMT, CRH, PTK7, TPH1
4MP:00107717.1ADORA2A, CCKBR, CRH, HTR3A, POMC, SLC6A2
5MP:00053856.6ADORA2A, CCKBR, COMT, HTR1A, MAOA, POMC
6MP:00053786.4ADORA2A, CCKAR, CCKBR, CRH, HTR3A, POMC
7MP:00036316.3ADORA2A, CCK, CCKAR, CCKBR, COMT, CRH
8MP:00053765.5ADORA2A, CCK, CCKAR, CCKBR, COMT, CRH
9MP:00053865.2ADORA2A, CCK, CCKAR, CCKBR, COMT, CRH

Drugs & Therapeutics for Panic Disorder

About this section

Drugs for Panic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 173)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Valproic Acidapproved, investigationalPhase 432799-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propyl-pentanoic acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VPA
Valcote
Valparin
Valproate
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
acide valproïque
acidum valproicum
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
ácido valproico
2
Paroxetineapproved, investigationalPhase 4, Phase 3, Phase 222861869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
3
NorepinephrineapprovedPhase 4, Phase 369951-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
4
CitalopramapprovedPhase 4, Phase 3, Phase 151259729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
5
Alprazolamapproved, illicit, investigationalPhase 4, Phase 2, Phase 16928981-97-72118
Synonyms:
28981-97-7
611026_ALDRICH
611026_FLUKA
8-Chloro-1-methyl-6-(phenyl-d5)-4H-(1,2,4)triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-alpha)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
A6551_FLUKA
A6551_SIGMA
A8800_SIGMA
AC-18721
AC1L1CYL
AKOS005066050
AP-1002
AZ-002
Alcelam
Algad
Alpaz
Alphapharm Brand of Alprazolam
Alplax
Alpram
Alprax
Alprazolam
Alprazolam (JP15/USP/INN)
Alprazolam Alphapharm Brand
Alprazolam Apotex Brand
Alprazolam Kenral Brand
Alprazolam Novopharm Brand
Alprazolam Nu-Pharm Brand
Alprazolam Orion Brand
Alprazolam Pfizer Brand
Alprazolam Temmler Brand
Alprazolam [USAN:INN:BAN:JAN]
Alprazolam extended release tablets
Alprazolam intensol
Alprazolam solution
Alprazolam-d5
Alprazolamum
Alprazolamum [INN-Latin]
Alprazolan
Alpronax
Alprox
Alviz
Alzam
Alzolam
Alzon
Anpress
Apo Alpraz
Apo-Alpraz
ApoAlpraz
Apotex Brand of Alprazolam
Arzneimittelwerk Dresden Brand of Alprazolam
Azor
BIDD:GT0475
BIDD:PXR0150
BRN 1223125
Bestrol
Bio-0790
C06817
CHEBI:2611
CHEMBL661
CID2118
CPD000149316
Cassadan
Constan
D 65MT
D-65MT
D000525
D00225
D65MT
DB00404
DEA No. 2882
EINECS 249-349-2
Esparon
Frontal
Gen-Alprazolan
HMS2051A10
 
HSDB 7207
Helex
I14-7472
Intensol
Kenral Brand of Alprazolam
Ksalol
LS-156344
MLS000559000
MLS000759485
Mialin
MolPort-002-507-836
NCGC00159466-02
NCGC00159466-03
Neurol
Niravam
Novo Alprazol
Novo-Alprazol
NovoAlprazol
Novopharm Brand of Alprazolam
Nu Alpraz
Nu Pharm Brand of Alprazolam
Nu-Alpraz
Nu-Pharm Brand of Alprazolam
NuAlpraz
Orion Brand of Alprazolam
Panistat
Panix
Pfizer Brand of Alprazolam
Pharnax
Prazam
Prazolan
Prinox
Ralozam
Relaxol
Restyl
SAM001246696
SMR000149316
STK590494
Solanax
Staccato-alprazolam
TGAR01P
TUS-1
Tafil
Tafil D
Temmler Brand of Alprazolam
Tensivan
Tranax
Trankimazin
Tranquinal
Tricalma
Tus 1
U 31889
U-31,889
U-31889
U31,889
UNII-YU55MQ3IZY
Unilan
Valeans
Xanagis
Xanax
Xanax (TN)
Xanax TS
Xanax XR
Xanolam
Xanor
ZINC00000903
Zacetin
Zanapam
Zaxan
Zenax
Zolam
Zolan
Zolarem
Zoldac
Zoldax
Zopax
Zopic
Zotran
alprazolam
nchembio747-comp35
6
DopamineapprovedPhase 4, Phase 3, Phase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
7
VortioxetineapprovedPhase 464508233-74-79966051
Synonyms:
4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium
 
BRINTELLIX
vortioxetine cation
8
SertralineapprovedPhase 4, Phase 2, Phase 3, Phase 129979617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-sertraline
sertraline
sertraline (Zoloft)
9
EthanolapprovedPhase 4, Phase 2, Phase 3, Phase 1213764-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
10
Aripiprazoleapproved, investigationalPhase 4358129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify Discmelt
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
CPD000466383
 
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
11
Risperidoneapproved, investigationalPhase 4, Phase 3, Phase 2492106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
12
ClozapineapprovedPhase 41175786-21-02818
Synonyms:
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
5786-21-0
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
AC-280
AC1L1EJE
AC1Q3OPZ
AC1Q3ZWP
AKOS005064444
AR-1I2412
Asaleptin
BRD-K37289225-001-09-1
BRN 0764984
Bio1_000436
Bio1_000925
Bio1_001414
Bio2_000310
Bio2_000790
C 6305
C06924
C18H19ClN4
C6305_SIGMA
CAS-5786-21-0
CCRIS 9171
CHEBI:3766
CHEMBL42
CID2818
CLOZARIL
CPD000058365
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
Clozapine
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
Clozapinum
Clozapinum [INN-Latin]
Clozaril
Clozaril (TN)
D00283
D003024
DB00363
DivK1c_000343
EINECS 227-313-7
EU-0100276
FT-0082373
Fazaclo
Fazaclo ODT
HF-1854
HF1854
HMS1361P12
HMS1569E21
HMS1791P12
HMS1921C16
HMS1989P12
HMS2089L13
HMS2092I16
HMS501B05
 
HSDB 6478
I06-0047
InChI=1/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3
Iprox
KBio1_000343
KBio2_000310
KBio2_000599
KBio2_002878
KBio2_003167
KBio2_005446
KBio2_005735
KBio3_000619
KBio3_000620
KBio3_002979
KBioGR_000310
KBioGR_001336
KBioSS_000310
KBioSS_000599
KS-1166
L000195
L013417
LEX-123
LS-60881
LX 100-129
Leponex
Lepotex
Lopac-C-6305
MLS000028472
MLS001077282
MolPort-001-728-041
NCGC00015254-01
NCGC00015254-02
NCGC00015254-03
NCGC00015254-07
NCGC00015254-17
NCGC00022902-02
NCGC00022902-04
NCGC00022902-05
NCGC00022902-06
NCGC00022902-07
NCGC00022902-08
NCGC00022902-09
NCGC00022902-10
NCGC00022902-11
NCGC00022902-13
NINDS_000343
Prestwick0_000350
Prestwick1_000350
Prestwick_693
S2459_Selleck
SAM002548976
SMR000058365
SPBio_000798
SPBio_002340
SPECTRUM1500685
Spectrum2_000919
Spectrum3_001828
Spectrum4_000898
Spectrum_000139
Tocris-0444
UNII-J60AR2IKIC
W-801
clozapine
clozapine(tautomer)
13
Clonazepamapproved, illicitPhase 4, Phase 2, Phase 3321622-61-32802
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
CID2802
CLONAZEPAM
Chlonazepam
Cloazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
DB01068
DEA No. 2737
 
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
LS-34156
LS-34260
Landsen
Lktorivil
Lonazep
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
RO4023
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
clonazepam
14
ZiprasidoneapprovedPhase 4145146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
15
Midazolamapproved, illicitPhase 472359467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
16
Ketamineapproved, vet_approvedPhase 45696740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
 
DEA No. 7285
DL-ketamine
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine [INN:BAN]
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
Kétamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
17Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 1, Early Phase 123689
18Muscarinic AntagonistsPhase 4, Phase 3, Phase 11166
19ParasympatholyticsPhase 4, Phase 3, Phase 11085
20Cholinergic AntagonistsPhase 4, Phase 3, Phase 11706
21Cholinergic AgentsPhase 4, Phase 3, Phase 1, Early Phase 13992
22Autonomic AgentsPhase 4, Phase 3, Phase 1, Early Phase 110150
23Antiparkinson AgentsPhase 4, Phase 3, Phase 11574
24Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 122062
25Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 13521
26Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 16430
27
SerotoninPhase 4, Phase 3, Phase 2, Phase 1362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
28Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 118340
29Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 23917
30Antidepressive Agents, Second-GenerationPhase 4, Phase 3, Phase 2, Phase 11311
31Cytochrome P-450 CYP2D6 InhibitorsPhase 4, Phase 3, Phase 2727
32Serotonin AgentsPhase 4, Phase 3, Phase 2, Phase 13156
33Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 11587
34Quetiapine FumaratePhase 4, Phase 2413111974-72-2
35Tranquilizing AgentsPhase 4, Phase 3, Phase 2, Phase 14265
36Antidepressive AgentsPhase 4, Phase 3, Phase 2, Phase 12736
37GABA AgentsPhase 4, Phase 2, Phase 3, Phase 11684
38Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 113403
39AnticonvulsantsPhase 4, Phase 2, Phase 3, Phase 12695
40Antimanic AgentsPhase 4814
41Antipsychotic AgentsPhase 4, Phase 3, Phase 22401
42Dopamine AntagonistsPhase 4, Phase 3, Phase 21093
43Central Nervous System StimulantsPhase 4, Early Phase 12211
44Serotonin 5-HT1 Receptor AgonistsPhase 4209
45Duloxetine HydrochloridePhase 4270
46Dopamine AgentsPhase 4, Phase 3, Phase 23836
47Serotonin 5-HT3 Receptor AntagonistsPhase 483
48Anti-Anxiety AgentsPhase 4, Phase 2, Phase 11885
49Serotonin and Noradrenaline Reuptake InhibitorsPhase 4, Phase 3457
50Hypnotics and SedativesPhase 4, Phase 2, Phase 12616

Interventional clinical trials:

(show top 50)    (show all 246)
idNameStatusNCT IDPhase
1Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled ReleaseUnknown statusNCT00492414Phase 4
2Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GADUnknown statusNCT00579280Phase 4
3The Efficacy and Tolerability of Duloxetine for the Treatment of Panic DisorderCompletedNCT00438971Phase 4
4A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder PatientsCompletedNCT00619892Phase 4
5A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic DisorderCompletedNCT00677352Phase 4
6Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic DisorderCompletedNCT00540098Phase 4
7Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic DisorderCompletedNCT00767754Phase 4
8Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic DisorderCompletedNCT00767871Phase 4
9Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder TreatmentCompletedNCT00803400Phase 4
10Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic DisorderCompletedNCT01551225Phase 4
11Evaluation of Clonazepam and Paroxetine for Panic Disorder With DepressionCompletedNCT00031317Phase 4
12A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic DisorderCompletedNCT02395510Phase 4
13Long Term Treatment of Panic Disorder With Clonazepam or ParoxetineCompletedNCT02852577Phase 4
14Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic DisorderCompletedNCT00266409Phase 4
15A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder PatientsCompletedNCT00198094Phase 4
16A Study of Risperidone Monotherapy in Bipolar AnxietyCompletedNCT00167479Phase 4
17Aripiprazole for the Treatment of Refractory AnxietyCompletedNCT00438386Phase 4
18Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)CompletedNCT01172652Phase 4
19The Effects of Treatment With Sertraline for Noncardiac Chest PainCompletedNCT01114100Phase 4
20A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac PatientsCompletedNCT01201967Phase 4
21Primary Care Intervention Strategy for Anxiety DisordersCompletedNCT00347269Phase 4
22A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With AnxietyCompletedNCT00229645Phase 4
23Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNCT00610909Phase 4
24Trial of Seroquel SR for Alcohol Dependence and Comorbid AnxietyCompletedNCT00352469Phase 4
25Non Cardiac Chest Pain and Benign PalpitationsCompletedNCT00623454Phase 4
26Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress DisorderCompletedNCT00391430Phase 4
27Pharmacotherapy in Depression With Panic SpectrumCompletedNCT00177996Phase 4
28Ketamine Infusion for Adolescent Depression and AnxietyRecruitingNCT02579928Phase 4
29Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersActive, not recruitingNCT00182533Phase 4
30Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder ComorbidityActive, not recruitingNCT01863459Phase 4
31Alcohol Research Consortium in HIV-Intervention Research ArmNot yet recruitingNCT02938377Phase 4
32A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic DisorderTerminatedNCT00635531Phase 4
33A Study to Assess the Long-Term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic DisorderTerminatedNCT00635076Phase 4
34A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic AttacksTerminatedNCT00634790Phase 4
35Mechanisms of Panic Disorders TreatmentUnknown statusNCT01323556Phase 2, Phase 3
36Psychotherapy Outcome and Self-selection Effects in Panic DisorderUnknown statusNCT01606592Phase 2, Phase 3
37Study Comparing Venlafaxine vs. Paroxetine in Panic DisorderCompletedNCT00195598Phase 3
38Psychodynamic Therapy for Treating Panic DisorderCompletedNCT00128388Phase 2, Phase 3
39Therapies for Treatment-Resistant Panic Disorder SymptomsCompletedNCT00118417Phase 2, Phase 3
40Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic DisorderCompletedNCT00845260Phase 3
41Comparison of Psychotherapy Programs to Treat Panic DisorderCompletedNCT00353470Phase 3
42Treatment of Panic Disorder: Long Term StrategiesCompletedNCT00000368Phase 3
43Study Evaluating Venlafaxine ER in Patients With Panic DisorderCompletedNCT00044772Phase 3
44Study Evaluating Venlafaxine ER in Adults With Panic DisorderCompletedNCT00038896Phase 3
45Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic AttacksCompletedNCT00279617Phase 3
46Treatment of Social Phobia and Panic Disorder in AdultsCompletedNCT00619138Phase 3
47Virtual Reality Exposure Therapy in Agoraphobic ParticipantsCompletedNCT00734370Phase 2, Phase 3
48Improving Quality of Primary Care for Patients With Anxiety and/or Panic DisordersCompletedNCT00102427Phase 2, Phase 3
49Telephone-Based Care Management Program for Individuals With Anxiety DisordersCompletedNCT00158327Phase 3
50Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety DisorderCompletedNCT00277654Phase 3

Search NIH Clinical Center for Panic Disorder

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: panic disorder

Genetic Tests for Panic Disorder

About this section

Genetic tests related to Panic Disorder:

id Genetic test Affiliating Genes
1 Panic Disorder 127

Anatomical Context for Panic Disorder

About this section

MalaCards organs/tissues related to Panic Disorder:

36
Heart, Cortex, Brain, Amygdala, Testes, Prefrontal cortex, Cingulate cortex

Publications for Panic Disorder

About this section

Articles related to Panic Disorder:

(show top 50)    (show all 1199)
idTitleAuthorsYear
1
Mental health service use, depression, panic disorder and life events among Swedish young adults in 2000 and 2010: a repeated cross-sectional population study in Stockholm County, Sweden. (28367775)
2017
2
Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder. (28068460)
2017
3
Contribution of Group Therapeutic Factors to the Outcome of Cognitive-Behavioral Therapy for Patients with Panic Disorder. (28359425)
2017
4
Reduction in Costs after Treating Comorbid Panic Disorder with Agoraphobia and Generalized Anxiety Disorder. (28418834)
2017
5
Burden and Distress in Caregivers of Patients With Panic Disorder and Agoraphobia. (27861457)
2017
6
Does patient reluctance towards exposure and psychologists' attitudes about evidence based practice influence treatment recommendations for panic disorder? An experimental investigation. (28325630)
2017
7
Psychoticism in patients with panic disorder with or without comorbid agoraphobia. (28345374)
2017
8
Perceived criticism predicts outcome of psychotherapy for panic disorder: Replication and extension. (28045286)
2017
9
The development and validation of static and adaptive screeners to measure the severity of panic disorder, social anxiety disorder, and obsessive compulsive disorder. (28370638)
2017
10
Erratum to: Effects of Mental Stress Induction on Heart Rate Variability in Patients with Panic Disorder. (28357597)
2017
11
Quality of Life in Patients with Coronary Artery Disease and Panic Disorder: A Comparative Study. (28042398)
2017
12
Association between personality traits and Escitalopram treatment efficacy in panic disorder. (28472591)
2017
13
Commonalities and differences in the neural substrates of threat predictability in panic disorder and specific phobia. (28331799)
2017
14
Translational approach to the pathophysiology of panic disorder: Focus on serotonin and endogenous opioids. (28073587)
2017
15
Functional neuroanatomy in panic disorder: Status quo of the research. (28401046)
2017
16
Panic Disorder Comorbidity with Medical Conditions and Treatment Implications. (28375724)
2017
17
The indirect effect of panic disorder on smoking cognitions via difficulties in emotion regulation. (28395248)
2017
18
Red Blood Cell and Platelet Indices: A Potential Biomarker for Panic Disorder. (28479785)
2017
19
Impact of childhood trauma on course of panic disorder: contribution of clinical and personality characteristics. (28369890)
2017
20
Distinct phasic and sustained brain responses and connectivity of amygdala and bed nucleus of the stria terminalis during threat anticipation in panic disorder. (28485259)
2017
21
Cardiac sarcoidosis resembling panic disorder: a case report. (28086847)
2017
22
Modeling the development of panic disorder with interoceptive conditioning. (27887860)
2017
23
Mean Platelet Volume and Platelet Distribution Width Level in Patients with Panic Disorder. (28479788)
2017
24
Sudden gains in exposure-focused cognitive-behavioral group therapy for panic disorder. (28493541)
2017
25
Basic Self-Disturbances beyond Schizophrenia: Discrepancies and Affinities in Panic Disorder - An Empirical Clinical Study. (28259879)
2017
26
Natriuretic Peptides in Anxiety and Panic Disorder. (28061968)
2017
27
White matter microstructural changes are associated with alcohol use in patients with panic disorder. (27085658)
2016
28
Factors associated with pain level in non-cardiac chest pain patients with comorbid panic disorder. (27777612)
2016
29
MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy. (27045843)
2016
30
Correction: Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment. (27907177)
2016
31
Serotonin Transporter and COMT Polymorphisms as Independent Predictors of Health-related Quality of Life in Patients with Panic Disorder. (27134498)
2016
32
Threat expectancy bias and treatment outcome in patients with panic disorder and agoraphobia. (27061246)
2016
33
Comorbid panic disorder as an independent risk factor for suicide attempts in depressed outpatients. (27095329)
2016
34
Insomnia Symptoms Following Treatment for Comorbid Panic Disorder With Agoraphobia and Generalized Anxiety Disorder. (27019339)
2016
35
Mobilization of Peripheral Blood Stem Cells and Changes in the Concentration of Plasma Factors Influencing their Movement in Patients with Panic Disorder. (27914035)
2016
36
The role of treatment delivery factors in exposure-based cognitive behavioral therapy for panic disorder with agoraphobia. (27235836)
2016
37
Agoraphobia Related to Unassertiveness in Panic Disorder. (26915016)
2016
38
Assessment of automatic associations with bodily sensations and agoraphobic situations in panic disorder. (27085983)
2016
39
Psychotherapies for Panic Disorder: A Tale of Two Sites. (27464313)
2016
40
Psychological dependence on antidepressants in patients with panic disorder: a cross-sectional study. (27496597)
2016
41
Cortisol awakening response in drug-naA^ve panic disorder. (27390521)
2016
42
A CASE OF ADVANCED NON-SEMINOMATOUS TESTICULAR GERM CELL TUMOR ACCOMPANIED PANIC DISORDER. (28132992)
2016
43
Developmental risk factors in generalized anxiety disorder and panic disorder. (27466747)
2016
44
Personality Disorders in Hypochondriasis: A Comparison to Panic Disorder and Healthy Controls. (27749185)
2016
45
Polymorphisms in the TMEM132D region are associated with panic disorder in HLA-DRB1*13:02-negative individuals of a Japanese population. (27081567)
2016
46
Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. (27730622)
2016
47
Predictors of Dropout From Cognitive-Behavioral Group Treatment for Panic Disorder With Agoraphobia: An Exploratory Study. (27385412)
2016
48
Predisposition or side effect of the duration: the reactivity of the HPA-axis under psychosocial stress in panic disorder. (27354161)
2016
49
Relative effects of cognitive and behavioral therapies on generalized anxiety disorder, social anxiety disorder and panic disorder: A meta-analysis. (27637075)
2016
50
Association between genes on chromosome 19p13.2 and panic disorder. (27610895)
2016

Variations for Panic Disorder

About this section

Expression for genes affiliated with Panic Disorder

About this section
Search GEO for disease gene expression data for Panic Disorder.

Pathways for genes affiliated with Panic Disorder

About this section

Pathways related to Panic Disorder according to GeneCards Suite gene sharing:

(show all 16)
idSuper pathwaysScoreTop Affiliating Genes
110.0CCK, CCKBR
29.9COMT, MAOA
3
Show member pathways
9.9COMT, MAOA
4
Show member pathways
9.7COMT, MAOA, SLC6A4
5
Show member pathways
9.6COMT, SLC6A2, SLC6A4
69.6CRH, POMC
79.3ADORA2A, CCKBR, HTR2A
8
Show member pathways
9.1COMT, MAOA, TPH1
9
Show member pathways
9.0ADORA2A, CCKAR, CCKBR, HTR2A
10
Show member pathways
8.4ADORA2A, MAOA, SLC6A2, SLC6A4, TPH2
128.0COMT, HTR1A, POMC, TPH1, TPH2
137.4HTR1A, HTR2A, HTR3A, MAOA, SLC6A4, TPH1
147.4HTR1A, HTR2A, HTR3A, MAOA, SLC6A4, TPH1
157.4HTR1A, HTR2A, HTR3A, MAOA, SLC6A4, TPH1
16
Show member pathways
7.3ADORA2A, CCK, CCKAR, CCKBR, CRH, HTR1A

GO Terms for genes affiliated with Panic Disorder

About this section

Cellular components related to Panic Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dendriteGO:00304259.9ADORA2A, CCK, COMT, HTR2A
2axonGO:00304249.5ADORA2A, CCK, COMT, HTR2A, HTR3A
3neuron projectionGO:00430059.1SLC6A2, SLC6A4, TPH1, TPH2
4neuronal cell bodyGO:00430258.6ADORA2A, CCK, CRH, HTR2A, HTR3A
5integral component of plasma membraneGO:00058878.5ADORA2A, CCKAR, CCKBR, HTR1A, HTR2A, PTK7
6integral component of membraneGO:00160217.3ADORA2A, CCKAR, CCKBR, COMT, HTR1A, HTR2A

Biological processes related to Panic Disorder according to GeneCards Suite gene sharing:

(show all 28)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of mitochondrial depolarizationGO:005190110.7CCK, TSPO
2cholecystokinin signaling pathwayGO:003818810.7CCKAR, CCKBR
3catecholamine metabolic processGO:000658410.7COMT, MAOA
4dopamine catabolic processGO:004242010.7COMT, MAOA
5neurotransmitter catabolic processGO:004213510.7COMT, MAOA
6adrenal gland developmentGO:003032510.7CRH, TSPO
7regulation of serotonin secretionGO:001406210.6CRH, HTR1A
8behaviorGO:000761010.6HTR1A, HTR2A
9dopamine uptake involved in synaptic transmissionGO:005158310.6SLC6A2, SLC6A4
10monoamine transportGO:001584410.6SLC6A2, SLC6A4
11regulation of behaviorGO:005079510.6HTR1A, HTR2A
12sensory perceptionGO:000760010.5ADORA2A, CCKBR
13positive regulation of glutamate secretionGO:001404910.5ADORA2A, CCK
14phospholipase C-activating G-protein coupled receptor signaling pathwayGO:000720010.3CCKAR, CCKBR, HTR2A
15positive regulation of cytosolic calcium ion concentrationGO:000720410.3CCKAR, CCKBR, HTR2A
16regulation of hormone secretionGO:004688310.3CCKAR, HTR1A, HTR2A
17serotonin receptor signaling pathwayGO:000721010.1HTR1A, HTR2A, HTR3A
18response to immobilization stressGO:003590210.1CRH, TPH1
19response to painGO:004826510.0COMT, CRH, SLC6A2, TSPO
20synaptic transmission, dopaminergicGO:000196310.0ADORA2A, CRH
21vasoconstrictionGO:00423109.9HTR1A, SLC6A4
22aromatic amino acid family metabolic processGO:00090729.9TPH1, TPH2
23indolalkylamine biosynthetic processGO:00462199.9TPH1, TPH2
24serotonin biosynthetic processGO:00424279.9TPH1, TPH2
25positive regulation of cell proliferationGO:00082849.8CCK, CCKBR, CRH, HTR1A, HTR2A
26circadian rhythmGO:00076239.6SLC6A4, TPH1, TPH2
27response to drugGO:00424938.9ADORA2A, COMT, CRH, HTR2A, SLC6A2, SLC6A4
28signal transductionGO:00071657.5ADORA2A, CCK, CCKAR, CCKBR, CRH, HTR1A

Molecular functions related to Panic Disorder according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1cholecystokinin receptor activityGO:000495110.6CCKAR, CCKBR
2dopamine:sodium symporter activityGO:000533010.5SLC6A2, SLC6A4
3monoamine transmembrane transporter activityGO:000850410.5SLC6A2, SLC6A4
4G-protein coupled serotonin receptor activityGO:000499310.0HTR1A, HTR2A, HTR3A
5serotonin bindingGO:005137810.0HTR1A, HTR2A, HTR3A
6hormone activityGO:000517910.0CCK, CRH, POMC
7amino acid bindingGO:00165979.8TPH1, TPH2
8oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygenGO:00167149.8TPH1, TPH2
9tryptophan 5-monooxygenase activityGO:00045109.1TPH1, TPH2
10signal transducer activityGO:00048718.6ADORA2A, CCKAR, CCKBR, HTR1A, HTR2A

Sources for Panic Disorder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet